PurchasingPolicy.orgPURCHASINGPOLICYBETA
← Back to Influence Map

Regulation Identification Number 0910-AJ05 Medical Devices; Laboratory Developed Tests; Implementation of Vacatur

introduced

On May 6, 2024, the Food and Drug Administration (FDA, the Agency, or we) issued a final rule amending the definition of "in vitro diagnostic products" in FDA's regulations. On March 31, 2025, a federal district court vacated that rule. This final rule reverts to the text of the regulation as it existed prior to the effective date of the May 2024 final rule.

No lobbying positions or financial data recorded for this regulation yet.

Public comment data and advocacy positions are added as they become available.